PRNewsWire
05 Aug 2026, 10:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Management will provide updates on recent corporate and regulatory developments during the August 12 conference call. — Regulatory updates in biopharmaceuticals can trigger significant price swings depending on whether they signal approvals or delays.
+0.20Protalix BioTherapeutics will release its Q2 2026 financial results and a business update on August 12, 2026. — Earnings announcements are standard volatility events, but the specific impact depends on the actual results released on that date.
+0.10Which stocks this story touches
Pfizer is mentioned only as a licensing partner for a specific therapy without any new material developments.
Continue reading
6 related stories
Top 1 mover · tap to explore
The company is announcing an upcoming earnings call and business update, which is a routine administrative announcement.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
2h ago
